Shandong Yingsheng Biotechnology Co., Ltd. has been a leader in the development and service of clinical mass spectrometry and gene detection technology in China since its establishment for more than ten years. Focusing on metabonomics and genemics, the company has built a leading gene detection platform and mass spectrometry detection platform in China. In terms of mass spectrometry detection platform, Yingsheng biology has successfully developed domestic leading full spectrum vitamin detection reagents, 48 diagnostic reagents for genetic and metabolic diseases, drug concentration and metabolism monitoring and other products and related report analysis software by using independent innovation technology. Meanwhile, it has cooperated with thermo through international cooperation Fisher, Hamilton, biotechnology, labsystems and other international companies have established close international partnerships, created a leading one-stop solution for clinical mass spectrometry automation, process, intelligence and standardization in China, become the most reliable technical means innovator for safeguarding the health of women and children in China, and actively promote the rapid development of precision medicine industry in China